Synthesis of Self-Assembled Nanoparticles and Drug Conjugates
- 2-Hydroxyoleic Acid as a Self-Assembly Inducer for Anti-Cancer Drug-Centered Nanoparticles
- Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles
- Self-assembling Releasable Thiocolchicine–Diphenylbutenylaniline Conjugates
- Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers
Synthesis of SARS-CoV-2 Mpro Inhibitors with Anticoronavirus Activity
Strategies for PROTAC Development
New Tools for the Treatment of Neurodegenerative Diseases
Development of Robust Methodologies Involving Boronic Acids
- Highly diastereoselective entry to chiral oxindole-based β-amino boronic acids and spiro derivatives
- Exploiting Enantiopure β-Amino Boronic Acids in Isocyanide-Based Multicomponent Reactions
- Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 Mpro Inhibitors
- Enantiopure β-isocyano-boronic esters: synthesis and exploitation in isocyanide-based multicomponent reactions
Chemoselective Methodologies for the Functionalization of Pyridine and other N-Hetherocycles
Biochemical Modulation of D-Asp Metabolism in Brain
…and soon to be started:
- Intestinal organoid-based models for drug discovery in pediatric inflammatory bowel disease (MUR- PRIN 2022)
- Validation of therapeutic candidates targeting HMGB1 to counteract muscular dystrophy (Telethon Round 3 2023, submitted)